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How is plasma calcium held constant? Milieu interieur of calcium.
Extracellular or plasma calcium ion concentration is held constant at 5
mg/dl through the actions of parathyroid hormone (PTH), vitamin D, and
calcitonin, on their target organs, kidney and bone. The thresholds of
renal tubular calcium reabsorption and bone resorption and formation are
both set at 5 mg/dl. The set point of PTH secretion is also set at 5 mgldl
plasma calcium ion. Therefore, the sensing system (parathyroid cell) and
the effectors, kidney and bone, are all set to maintain plasma calcium at 5
mgldl, perhaps through membrane-bound calcium sensor proteins. The
effectiveness of this system depends upon the presence of bone remodel-
ing, which allows a swift shift of plasma calcium from and to bone in
response to PTH and calcitonin, respectively. In this regard, directing
hematopoiesis to bone marrow that provides bone resorbing osteoclasts is
critical. It is likely that this shift of hematopoiesis occurs through evolution
at the transition from the aquatic to the terrestrial life, and this event is
directed by expression of "homing molecule" in bone marrow stromal
cells. This brief review provides a factual and conceptual framework of the
current understanding of the milieu interieur of the calcium ion.
Calcium ion concentrations in the extracellular fluid (ECF) or
plasma are held constant within a narrow range of about 5 mgldl.
This is achieved primarily by the actions of parathyroid hormone
(PTH), vitamin D and calcitonin. The major target organs of these
hormones are the kidney, bone and intestine. It is well known that:
(1) both PTH and vitamin D raise plasma calcium; (2) without this
regulation, plasma calcium level always falls, and PTH and
vitamin D restores calcium to normal levels; (3) both parathyroid
cells and calcitonin secreting C cells of the thyroid gland sense
subtle deviations in plasma calcium from the normal value of 5
mgldl. Thus, parathyroid gland must be central to the mainte-
nance of plasma calcium concentration within a normal range.
In response to a fall in plasma calcium, parathyroid cells sense
this fall and secrete PTH into the circulation. PTH then acts on
two main target organs, kidney and bone. This review will briefly
examine our concept of the "set point" for the calcium flux
between ECF and bone, and the "set point" of renal tubular
calcium reabsorption, as previously discussed in a "Nephrology
Forum" of Kidney International [1] and in a recent review [2]. This
"set point" concept is further advanced by examination of the
action of vitamin D on parathyroid cells giving insights into the
evolution of calcium regulating systems.
Set point of renal tubular calcium reabsorption
In the kidney PTH activates the vitamin D system. As reviewed
previously [31, studies by Suda and associates and by us have
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shown that PTH stimulates 1 a-hydroxylase in the proximal con-
voluted tubules via cyclic AMP, leading to the accerelated con-
version of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D
(1,25D), the active metabolite of vitamin D. Consequent to
activation of the vitamin D system, PTH stimulates the renal
tubular reabsorption of filtered calcium, presumably in distal
nephron segments. Vitamin D also affects the intestine to enhance
absorption of orally taken calcium, thereby participating in the
body economy of calcium. Intestinal calcium absorption may
transiently affect plasma calcium, but it does not participate in the
regulation of the steady-state plasma calcium ion concentration.
Studies in the rat in vivo showed that the presence of both PTH
and vitamin D is needed to maintain renal tubular reabsorption of
calcium at normal levels [1, 2, 4J. In normal rats with both PTH
and vitamin D present, urinary calcium excretion will increase
linearly when calcium is constantly infused to raise plasma calcium
above 5 mg/dl. This indicates the presence of a threshold and
tubular maximum for calcium reabsorption as well as a set point
of calcium reabsorption to maintain normal plasma calcium
concentration at 5 mg/dl. However, in the absence of either PTH
or vitamin D this apparent set point for calcium reabsorption
decreases, so that attempts to raise serum calcium toward normal
by intravenous calcium infusion result in a linear increase in
urinary calcium excretion without effectively restoring plasma
calcium to normal. In the absence of both PTH and vitamin D,
this set point progressively decreases. This can be seen in patients
with hypoparathyroidism. When one attempts to raise serum
calcium to normal by giving the active form of vitamin D (a
common practice in clinical medicine), serum calcium ion will
increase to about 3 to 4 mg/dl, a level lower than normal. Giving
more vitamin D to further raise plasma calcium toward normal
will lead to a marked and linear increase in urinary calcium
excretion, sometimes prohibitively high in excess of 200 to 300 mg
per day [11. This happens because of the continued absence of
PTH in this setting. Therefore the set point for renal tubular
calcium reabsorption remains low and cannot be normalized
without PTH. Administration of PTH alone will completely
correct the calcium abnormalities in hypoparathyroid patients,
because PTH will provide vitamin D by stimulating 1 a-hydroxy-
lase in the kidney, but such a regimen is not practical at present.
The site along the nephron of action of the PTH and vitamin D
regulation of calcium reabsorption set point appears to be distal
nephron segments. Studies in isolated perfused tubules and in
cultured tubule cells [5, 6] suggest that the target may be
connecting tubule cells. In addition, the presence of vitamin D
receptors as well as vitamin D inducible calcium-binding protein
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Bone-ECF ECF-renal tubule
1. 5 mg/dl 5 mgldl
Normal condition
2. 5 mg/dl 4 mgldl
Calcium released from bone is quickly and
continuously lost in urine
3. 4 mg/dl 5 mgldl
Calcium absorbed from gut never appears in
urine and accumulates in bone
or calbindin in distal nephron has been shown [1, 3, 7]. Nonethe-
less, recent studies using molecular probes for calcium-sensing
cell surface receptors that are coupled to G-proteins in parathy-
roid glands [8, 9] also reveal the presence of these calcium
receptors and PTH receptors in distal nephron segments [8—111.
These observations are consistent with the notion that it is the
distal nephron where the set point of calcium reabsorption is
present and regulated.
Set point of calcium flux between bone and extracellular fluid
Bone is constantly resorbed and formed through the actions of
bone cells. Osteoclasts resorb bone and osteoblasts form new
bone in a process called bone remodeling. Available data show
that both PTH and vitamin D act on osteoblasts, and that this
action somehow stimulates bone resorption by osteoclasts, prob-
ably through cytokines released from osteoblasts.
Rates of bone resorption and formation are held constant and
coupled to maintain the bidirectional flux of calcium between
bone and ECF. Indeed, in normal humans, about 500 mg per day
of calcium is released from bone through bone resorption, and
500 mg per day of calcium is taken up to the bone through bone
formation. More important is the fact that bidirectional calcium
flux between bone and ECF is set to maintain ECF calcium ion
concentration at 5 mgldl. In the absence of PTH, serum calcium
falls, but the bidirectional calcium flux between bone and ECF
continues, albeit at a slower rate due to slower rate of bone
resorption and formation, as may be seen in patients with
hypoparathyroidism. Under these conditions, the set point for
calcium between the bone and ECF interphase is at a low level,
similar to the lowering of set point for renal tubular calcium
reabsorption in hypoparathyroidism.
It is very likely that both PTH and vitamin D, in concert, adjust
the set point for calcium between bone and ECF interphase and
the set point of renal tubular calcium reabsorption always to the
same level. If the set points in these two organ systems, that is,
bone and kidney are different, what would happen? The likely
scenarios are outlined in Table 1. For example, in a situation in
which the set point for calcium between bone and ECF is normal
at 5 mg/dl and higher than that in the kidney (for example, 4
mg/dl), calcium released from bone would quickly and continu-
ously be lost in the urine, because filtered calcium would not be
reabsorbed to the level of calcium set by bone-ECF interphase. A
result will be a continuous and fairly fast loss of bone calcium to
the urine. Conversely, if the set point for calcium reabsorption in
the kidney is higher than that in bone-ECF interphase, there
would be no calcium appearing in the urine. Any calcium ab-
sorbed from the intestine after each meal would not be excreted
()
Fig. 1. Schematic presentation of our current view of the regulation of
plasma calcium concentration. It is emphasized that: (1) the effects of
vitamin D on parathyroid cell (PTG) play an important role in setting its
ECF calcium sensor protein to respond to a deviation of ECF calcium
from 5 mg/dI; (2) the set point of renal tubular calcium reabsorption is set
at 5 mg/gl; and (3) bone-ECF interphase is also Set at 5 mg/dl. Reproduced
from [11 with permission.
in the urine and will continuously accumulate in bone. Since such
abnormalities outlined in scenarios #2 and #3 of Table 1 rarely
exist in any clinical settings, it is reasonable to assume that the set
points for calcium between bone and ECF interphase as well as
ECF-renal tubule interphase must be set by both PTH and
vitamin D, but always at the same level.
Thus, a subtle fall in plasma calcium ion concentration is sensed
by parathyroid cells, which then release PTH. PTH then activates
vitamin D production in the kidney, and these two hormones
determine the set points between bone and ECF and renal tubular
calcium reabsorption. An excess of calcium in the plasma will be
excreted in the urine, and a fall in plasma calcium will be met by
an increased release of calcium from bone to restore plasma
calcium level to normal. This is schematically depicted in Figure 1.
Set point of parathyroid hormone secretion
Parathyroid cells are very sensitive calcium sensors. A slight fall
in plasma calcium will immediately stimulate PTH release, and a
slight increase in plasma calcium will result in an immediate
suppression of PTH secretion. It is clear that the PTH release is
set to function most effectively in response to a deviation from
normal ECF calcium concentration. The plasma Ca at which PTH
release is half suppressed is called the "set point" of PTH
secretion observed in a "sigmoidal curve" of plasma Ca versus
PTH release [121.
We have learned a great deal about the regulation of PTH
secretion from observations of secondary hyperparathyroidism in
chronic dialysis patients and in animal models of chronic renal
failure (see Ritz, this issue). Results from normal and chronically
uremic patients as well as from experimental animals have
Table 1. Set points for calcium fluxes PTG
Reproduced from [2] with permission.
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demonstrated the direct effects of vitamin D on parathyroid cell
function via binding to vitamin D receptors. These effects include:
(1) regulation of the set point of PTH secretion in response to a
change in ECF calcium; (2) regulation of PTH synthesis; (3)
regulation of cell proliferation; and (4) induction of apoptosis and
cell death [12—141.
It is likely that a subtle change in ECF calcium ion concentra-
tion will be sensed by the calcium sensing protein in a G-proptein
coupled manner [8, 11], but the receptor-mediated mechanism by
which vitamin D regulates the set point of PTH secretion and the
expression and function of the calcium sensing receptor protein
are unknown. Nevertheless, inspection of the sigmoidal curve of
PTH secretion in normal subjects show that the set point of PTH
secretion is set to respond most sensitively and effectively to a
deviation of ECF calcium ion from 5 mg/dl [12]. Thus the ECF
calcium ion concentration is set to be maintained at about 5 mgldl
(Fig. 1).
It is suggested that vitamin D regulates how much PTH is
produced by regulating PTH mRNA and also parathyroid cell
number by regulating cell growth. In case of need of PTH, vitamin
D allows parathyroid cells to proliferate, and in the case of excess
parathyroid cells, vitamin D can induce apoptosis thereby decreas-
ing the number of functioning parathyroid cells. Again, it is clear
that the interplay of PTH and vitamin D will set ECF calcium at
5 mg/dl most effectively by adjusting the set points of bone-ECF,
kidney tubules and parathyroid cells, and in addition, parathyroid
cell number.
Physiology of calcitonin
It is well known that calcitonin is necessary to effectively reduce
plasma calcium in response to a calcium load. Following an
intravenous calcium load in experimental animals with intact
thyroid glands, plasma calcium quickly returns to normal due to
the inhibition of osteoclastic bone resorption by calcitonin, which
allows rapid calcium deposition to bone. In contrast, this response
is sluggish in the absence of thyroid gland. Thus, in the absence of
calcitonin, an increase in plasma calcium will return to normal,
primarily through urinary calcium excretion, which takes over 24
hours, rather than calcium deposition in bone, which takes only a
few hours.
We do not spontaneously become hypercalcemic. Plasma cal-
cium increases only transiently after ingestion of meals containing
calcium. Calcitonin secreted in response to postprandial hyper-
calcemia facilitates the net transfer of calcium to bone by tran-
siently suppressing bone resorption [15]. Such an action may be
necessary for growing stages of life, such as pre- and post-natal
periods and childhood. Indeed, intestinal calcium absorption is
the only route for calcium entry into the body and during growth
the need for calcium increases in support of skeletal growth. We
believe that in this process calcitonin plays its principal physio-
logical role [1, 3]. In this regard, it is well known that calcitonin is
high in fetal circulation, and that calcitonin secretion is most
effective in the young and decreases with age.
Milieu interieur of calcium and its evolution
The parathyroid gland and PTH appear in the evolution of
amphibia, reptiles, birds, and mammals. Prior to amphibia, te-
leosts lived in sea water in which calcium ion concentration is
about 40 mg!dl, ten times higher than prevailing calcium concen-
trations in the plasma of fish as well as mammals. Evolution of
parathyroid hormone may be better understood if one considers
calcium regulation of the milieu interieur or the extracellular fluids
of creatures in sea water as well as those on the land as
schematically shown in Figure 2. As can be seen in the left, it is
clear that in teleost, the gill rather than the kidney may assume the
primary role to maintain milieu interieur. By contrast as shown in
the right, for the terrestrial life, the kidney is the only organ which
regulates electrolyte and fluid excretion in quantities which match
their inputs to maintain milieu interieur.
In seawater teleost fish there is no need to raise ECF calcium,
thus no PTH. Rather, they have to defend themselves from
hypercalcemia from sea water that contains 40 mgldl calcium.
Thus, bone of teleosts has very few bone cells, no need for bone
resorption, and no need for agents to raise ECF calcium. With the
evolution of terrestrial life, one now has no guarantee to maintain
normal ECF calcium via calcium intake through the gut. Accord-
ingly, terrestrial life had to acquire the machinary to sense
constantly falling ECF calcium (that is, parathyroid cells) and a
system or a body calcium reservoir to provide calcium (that is,
bone), as well as agents to raise ECF calcium (PTH and vitamin
D), which resorb bone and release calcium to ECF. This calcium
regulating system is one of the critical contributors to homeostasis
of the milieu interieur of our body. In addition to the large calcium
depot, bone has taken on the task of sustaining body posture in a
field of gravity, as discussed below. Receptors for both PTH and
calcitonin have been cloned [16, 17]. The amino acid sequence of
these two receptors revealed seven transmembrane domains, like
other peptide hormone receptors, but these two receptors have no
significant homology to many receptors that are thought to span
plasma membranes seven times and to interact with G proteins,
with a few exceptions such as the secretin receptor. More impor-
tantly, however, these two receptors share about 40% homology
with each other [16, 17], suggesting that the emergence of PTH
and calcitonin systems must have a common reason in the
evolution of our life.
It should be noted that for this calcium regulating system to
function effectively, the calcium reservoir must undergo constant
resorption and formation, allowing a swift response to provide
calcium to the ECF in response to a fall in ECF calcium. Also,
calcium acquired from the gut after ingestion of a meal must be
effectively transferred to bone when needed. To ensure such a
skeletal system, bone cells, which resorb and form bone, must be
critically important. Stated in another way, bone remodeling with
constant bone resorption and formation is an essential component
of this highly effective calcium homeostatic system.
Where do osteoclasts come from?
There has been a debate over the origin of osteoclasts, that is,
whether or not the osteoclast originates from a hematopoietic
stem cell [18]. From the perspective of evolution, the sites where
blood cells are produced, or the site of hematopoiesis, is an
interesting subject [19, 20]. As depicted in Table 2, hematopoiesis
takes place in the kidney in fish. In aquatic amphibia, it takes place
in the spleen. Hematopoiesis moves to bone marrow, first in the
terrestrial amphibia, then in reptiles, birds, and mammals. Even in
mammals during fetal life, hematopoiesis takes place first in the
yolk sac, then in the spleen, and finally in the liver. Only after
birth, hematopoiesis takes place in bone marrow. These observa-
tions strongly suggest that hematopoiesis needs not to be in bone
marrow, and that only after assuming terrestrial life, as in
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Fig. 2. Milieu interieur of the calcium. In teleost on the left, the calcium concentration of the sorrounding environment is higher than that of the
extracellular fluid or plasma, thus there is no need for the system to raise plasma calcium. Further, the gill (an open arrow in the middle at the right
of the left figure) plays a significant role in the maintenance of milieu interieure, and the kidney (an open arrow in the lower right of the left figure) may
not function as critical an organ to maintain the milieu interieure as in mammals as shown on the right. In mammals (or amphibia, reptiles, and birds)
shown on the right, the kidney is the only route of regulated outputs of fluid and electrolytes for the maintenance of the mileiu interieure. In addition,
in the case of terrestrial life, constant bone resorption and formation which provides calcium from a large calcium store that is, bone, is necessary to
maintain plasma calcium concentration which always tends to fall. Moreover, bone becomes a necessity to maintain body wt against gravity. Reproduced
from [2] with permission.
Site of hemopoiesis
Phylogeny
Teleost kidney
Amphibia
aquatic spleen
terrestrial bone marrow
Reptiles bone marrow
Birds bone marrow
Mammals bone marrow
Ontogeny in mammals
Fetus yalk sac — spleen —* liver
After birth bone marrow
mammals after birth, it moves to the bone marrow. This indicates
that hematopoiesis will shift to bone marrow when the skeleton
needs to serve as the calcium reservoir and as the mechanical
support for the body weight against gravity. Thus, there is no
question in my mind why osteoclasts have originated from a
hematopoietic stem cell, because "bone resorption by osfeoclasts
has become a fundamental necessity for terrestrial life to sustain
ext racellular calcium concentration and to sus fain body weight
against gravity."
What induces the bone marrow homing molecule?
My assertion about the hematopoietic origin of osteoclasts
raises an intriguing question. What is the factor which directs
hemopoiesis to bone marrow? In bone marrow transplants, blood
samples are taken from bone marrow of the donor and given
intravenously to the recipient. Subsequently, cells supposed to
reside in bone marrow quickly disppear from the systemic circu-
lation and settle in the bone marrow. How this is possible? The
answer to this question are "homing molecule(s)" expressed by
bone marrow stromal cells which specifically are recognized by
bone marrow cells and immature hematopoietic cells [21]. Thus,
transfused hematopoitetic stem cells and immature cells recog-
nize this homing molecule and attach themselves to the microen-
vironment of the bone marrow of the recipient. The evolution of
hematopoiesis as depicted in Table 2, thus strongly suggests that
either players in calcium regulating system or factors related to
gravity must be responsible for inducing the homing molecule in
bone marrow stromal cells. These hypotheses have not been
tested, hut would be of great interest for future investigations.
-w
0.9% NaCI
5 mg/dl Ca
Table 2. Phylogeny and ontogeny of hematopoiesis
Reproduced from [21 with permission.
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Conclusions
In this brief review presented at the symposium celebrating the
100th year of Homer Smith's birth, I outlined my concept on the
calcium regulating system in our body. Laboratory and clinical
investigations have certainly contributed greatly to the concepts
developed here. Specifically, I wish to emphasize that it is often
useful to look into the evolution of a particular system, since the
functions of our body must have come a long way. From the
vantage of evolution, we can better understand why and how we
live with great freedom, flexibility, and relative independence
from our sorrounding environment by way of impressive abilities
to maintain the milieu inrerieur. We realize that there are many
questions we should ask ourselves as nephrophiles. For example,
why does vitamin D activation take place exclusively in the kidney
and in proximal tubules? Why is erythropoietin produced in the
kidney? Why do well differentiated tubule cell types align them-
selves along the nephron? As I discussed above, using the calcium
regulating system as an example, the analysis of a system with an
evolutionary perspective may somtimes give us better, and per-
haps more rational insights into the biology, physiology, and
pathophysiology of that system in our body. This applies particu-
larly to the kidney since the kidney has assumed the major and
most critical role in the maintenance of milieu interieur of our
body during the transition from aquatic to terrestrial life.
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